Applied BioMath, LLC announces live webinar on Quantitative Systems Pharmacology Modeling (QSPM) in Immuno-oncology

Applied BioMath (, the industry-leader in applying mechanistic modeling to drug development, today announced an upcoming live webinar:

“Quantitative Systems Pharmacology Modeling (QSPM) Case Study in Immuno-oncology”

to be held on Tuesday, April 12, 2016 at 11am ET/8am PT, hosted by Fierce Markets.


Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath, will discuss the value of QSPM approaches in drug R&D and present an industry case study in immuno-oncology.   The case study entails developing and interrogating a QSPM of PD-1 and TIM-3. The QSPM provided:

  • Biological insights by predicting why dosing regimens are quite similar for two therapeutics targeting PD-1 that have affinities that differ by several orders of magnitude
  • Best-in-class profile predictions for PD-1 and TIM-3 dual antagonists

This webinar is ideal for scientists in R&D who want to learn more about how to leverage QSPM to shorten timelines, lower cost, and increase the likelihood of developing best-in-class drugs.

View full press release